BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1353939)

  • 41. [Multiple endocrine adenomatosis type II-a: presentation of a stricken family].
    García H; Pou J; Moreiro J
    Med Clin (Barc); 1987 May; 88(17):689-92. PubMed ID: 2886708
    [No Abstract]   [Full Text] [Related]  

  • 42. [Multiple endocrine neoplasm syndrome (MEN-2a) or Sipple syndrome. Report of 2 cases].
    Sánchez Román J; Morales Méndez S; Conde García J; Vaquero Ruiz F
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):45-9. PubMed ID: 6138823
    [No Abstract]   [Full Text] [Related]  

  • 43. Multiple endocrine neoplasia type 2A: a Northern Ireland and Australian family.
    Hadden DR; O'Reilly F; Kennedy L; Russell C
    Henry Ford Hosp Med J; 1987; 35(2-3):107-9. PubMed ID: 2891640
    [No Abstract]   [Full Text] [Related]  

  • 44. Characteristics of a family with the MEN-2A syndrome.
    Haak HR; Nieuwenhuijzen Kruseman AC
    Henry Ford Hosp Med J; 1987; 35(2-3):104-6. PubMed ID: 2891639
    [No Abstract]   [Full Text] [Related]  

  • 45. Medullary thyroid carcinoma: Australian experience with genetic testing.
    Ward JL; Hyland VJ; Andrew DS; Marsh DJ; Robinson BG
    Henry Ford Hosp Med J; 1992; 40(3-4):220-3. PubMed ID: 1362409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Presence of the RET Cys634Tyr mutation and Gly691Ser functional polymorphism in Iranian families with multiple endocrine neoplasia type 2A.
    Aghdam MN; Abbaszadegan MR; Tafazoli A; Aslzare M; Mosavi Z
    Hormones (Athens); 2016; 15(1):65-72. PubMed ID: 26732158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple endocrine neoplasia.
    Decker RA; Wells SA
    Jpn J Surg; 1989 Nov; 19(6):645-57. PubMed ID: 2575183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presymptomatic identification of carriers of the multiple endocrine neoplasia type 2A gene using flanking DNA markers.
    Howe JR; Lairmore TC; Dou S; Mishra SK; Dilley WG; Donis-Keller H; Wells SA
    Surgery; 1992 Aug; 112(2):219-25; discussion 225-6. PubMed ID: 1353639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The gene for mannose-binding protein maps to chromosome 10 and is a marker for multiple endocrine neoplasia type 2.
    Schuffenecker I; Narod SA; Ezekowitz RA; Sobol H; Feunteun J; Lenoir GM
    Cytogenet Cell Genet; 1991; 56(2):99-102. PubMed ID: 1672848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A genealogical study from an area of endemic degeneration.
    Kremenová J; Reisenauer R
    Acta Univ Carol Med (Praha); 1984; 30(1-2):43-63. PubMed ID: 6150628
    [No Abstract]   [Full Text] [Related]  

  • 51. A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A.
    Lichter JB; Hackleman SM; Ponder BA; Easton D; Narod SA; Lenoir GM; Gagel RF; Simpson NE; Gardner E; Goodfellow PJ
    Henry Ford Hosp Med J; 1992; 40(3-4):205-9. PubMed ID: 1362406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A).
    Donghi R; Sozzi G; Pierotti MA; Biunno I; Miozzo M; Fusco A; Grieco M; Santoro M; Vecchio G; Spurr NK
    Oncogene; 1989 Apr; 4(4):521-3. PubMed ID: 2566146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
    Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
    J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linkage analysis of multiple endocrine neoplasia type 2A (MEN-2A) and three DNA markers on chromosome 20: evidence against synteny.
    Farrer LA; Goodfellow PJ; White BN; Holden JJ; Kidd JR; Simpson NE; Kidd KK
    Cancer Genet Cytogenet; 1987 Aug; 27(2):327-34. PubMed ID: 2885081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The multiple endocrine neoplasm type-IIb syndrome].
    Kazeev KN; Lisnianskiĭ IE; Zaletaev DV; Kuratev LV; Avdeeva TF
    Probl Endokrinol (Mosk); 1988; 34(6):45-7. PubMed ID: 2907132
    [No Abstract]   [Full Text] [Related]  

  • 59. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
    Yang KP; Nguyen CV; Castillo SG; Samaan NA
    Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma.
    Grauer A; Raue F; Gagel RF
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):613-35. PubMed ID: 1979773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.